Project Grant K08CA288912
Award Date
8/1/24
Completion Date
11/30/29
Dollars Obligated
$563K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award for $166,984 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports efforts to increase enrollment of adolescent and young adult (AYA) cancer patients on clinical trials at the Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins University. The project will develop and implement an "AYA: ALERT, Young Adult Navigation, Alliance" system to identify eligible AYA patients, provide them with timely information about...
The National Cancer Institute (NCI) awarded a $253,273 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Dana-Farber Cancer Institute, Inc. (DFCI) for the project "VALIDATION AND IMPLEMENTATION OF CTDNA AS A CLINICALLY INFORMATIVE BIOMARKERIN AYAS WITH SARCOMAS." The grant aims to validate circulating tumor DNA (ctDNA) as a prognostic biomarker for adolescents and young adults (AYAs) with sarcomas, including Ewing sarcoma, synovial sarcoma, osteosarcoma, and...
The National Cancer Institute (NCI) awarded a $664,259 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Duke University. The grant is for the development and evaluation of the "AYA STEPS" digital health intervention, which aims to help adolescent and young adult (AYA) cancer survivors manage their symptoms and improve engagement with post-treatment care. The project involves a randomized controlled trial to assess the efficacy of the AYA STEPS...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $161,432 to The University of Texas MD Anderson Cancer Center to develop and evaluate a virtual, group-based expressive writing intervention for adolescent and young adult cancer survivors (AYACSS). The overarching goal is to enhance the quality of life and reduce stress among this population, who face multiple psychosocial disparities. The award will fund a 2-year research plan with the...
The National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), awarded a $540,090 Project Grant to The Regents of the University of California, San Francisco (UCSF) to conduct research on osteosarcoma, a type of bone cancer that primarily affects children and young adults. The research aims to characterize the epigenetic heterogeneity of osteosarcoma and identify potential subtypes driven by distinct transcription factor networks. Key...
This federal Project Grant award of $692,417, funded by the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), supports research to elucidate and define accelerated cardiac aging in a diverse cohort of adolescent and young adult (AYA) cancer survivors. The research will be conducted by the University of Texas MD Anderson Cancer Center, in collaboration with the University of Texas Health Science Center at Houston and Cook Children's Health Care...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Research Manpower program (CFDA 93.398), will support research conducted by the Dana-Farber Cancer Institute (DFCI) to investigate the role of the protein IGF2BP1 as a potential therapeutic target for Ewing sarcoma, a prevalent pediatric bone cancer. The $514,196 award will fund a 3-year research project that aims to: 1) validate IGF2BP1 as a novel dependency for Ewing sarcoma using CRISPR-Cas9 knockout...
This National Cancer Institute (NCI) Project Grant award to Georgetown University, under the Cancer Biology Research program (CFDA 93.396), provides funding of $401,115 to develop a 3D bioengineered microfluidic platform (3D-BMP) to study the mechanisms of Ewing sarcoma bone metastasis. The project aims to utilize this 3D-BMP model to perform CRISPR screens and identify key genetic drivers of Ewing sarcoma's ability to metastasize to bone, a common occurrence that is associated with poor...
This $290,052 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports the development and evaluation of a mobile-optimized intervention called PERCS-YA (Personalized Cancer Support for Young Adults) to reduce worry and distress among young adult cancer survivors. The award will fund stakeholder-engaged refinement of the PERCS-YA intervention, followed by a Phase II efficacy trial utilizing both a...
This $216,460 Project Grant awarded by the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) supports research at Case Western Reserve University to study the epigenetic drivers of lung metastasis in osteosarcoma. The key goals are to characterize the transcription factors and enhancer activity that promote lung metastasis in osteosarcoma, and to understand how the lung microenvironment influences this metastatic process. The research aims to elucidate the...